Skip to main content

Advertisement

Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats

Fig. 3

Left atrial interstitial fibrosis in the study groups. a Control group; b diabetes mellitus (DM) group; c low-dose empagliflozin group; d high-dose empagliflozin group; e Illustrates the quantitative ratio of the area of fibrosis to the area of the reference area. Each group included 5–8 rats.*Compared with the control group, p < 0.05; **Compared with the DM group, p < 0.05

Back to article page